Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers

Launched by CHU DE REIMS · Oct 11, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help diagnose bladder cancer by looking at urine samples. The researchers are using special techniques called infrared and Raman spectroscopy, which are methods that can analyze the chemical makeup of the urine to see if there are signs of cancer. This trial is currently looking for participants, and both men and women aged 18 and older who have been referred for a urology consultation and are able to provide consent may be eligible to join.

If you decide to take part in this study, you will contribute to understanding how these new methods can improve bladder cancer diagnosis. It’s important to note that people who have certain conditions, such as not having a native bladder or having a bladder fistula, cannot participate. By participating, you could help researchers find better ways to identify bladder tumors, which may lead to improved care for patients in the future.

Gender

ALL

Eligibility criteria

• inclusion criteria:
• • Must be over 18 years of age
• • Able to give consent and understand the purpose the study
• • Agree to participate in the study and having signed the non-objection document
• • Admitted to a urology consultation for cystoscopy
• • exclusion criteria: Patients with any of the following criteria will not be included in the study
• • Refused to participate in the study or unable to give consent
• • without a native bladder
• • with a bladder fistula